August - 2021
| Previous Next | Showing Journal 5 of 6 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic ShockR Matthew, P Di Santo, R Jung et al New Eng J Med, 2021, 385:516-25 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
August |
Previous Comments
No Comments yet.
Comment
How do the two “inodilators”, milrinone and dobutamine compare as treatments for cardiogenic shock? Common teaching says milrinone is a more effective pulmonary vasodilator, and less arrhythmogenic.
The DOREMI trial sets out to answer this. This is how;
...